wd_title.gif (9711 bytes)


Stanislaw R Burzynski, MD, PhD

"I'm going to fight no matter what they do, because I believe I'm doing the right thing. I believe that this is our obligation to the people. If you find something that's valuable, you must continue, and I believe we've found something that saves lives." Stanislaw Burzynski, MD, PhD

 In 1970, Dr. Stanislaw Burzynski left the repressive communism of Poland for the freedom of America. Little did he suspect that twenty years later he’d wind up in a Texas courtroom facing trumped up charges and up to 270 years in prison—for curing cancer.

In 1967 Stanislaw Burzynski, at the age of 24, graduated with honors from the Lublin Medical Academy. Just a year later, he became one the youngest geniuses in Poland to earn a doctorate in biochemistry and hold two degrees.

He went onto graduate school because of a passion he’d developed in medical school concerning amino acids, which are the basic building blocks of proteins. His early investigations were to determine if the levels of various amino acids in the blood stream could be used to diagnose specific diseases. While doing this, he also learned that there were small proteins in the blood that were very similar to amino acids, but they’d never been identified. Burzynski identified them as peptides, complex molecules built from amino acids. He then discovered that a patient suffering from prostate cancer had very low levels of these peptides. He tested other cancer patients and discovered the same deficiency. This led Burzynski to develop his theory that it was these peptides that defended the body against cancer.

Unable to continue any further in Poland, he left for America with twenty dollars in his pocket, a theory in his head, and an indefatigable attitude that shown in his smile.

Burzynski found work at Baylor College of Medicine in Texas and quickly became a rising star in cancer research. Where modern science had seen these peptides in the blood as debris from the breakdown of proteins, Burzynski saw them as “information carriers” that the cancer cells just aren’t getting. With the correct information, the body would stop creating cancer and again create healthy cells.

While focusing on blood, Burzynski realized that he constantly needed more and more blood to collect his peptides. Colleagues and friends began avoiding him. They could only give him so much blood. Burzynski, like most creative geniuses, turned to another bodily fluid, urine, to look for his peptides, and in doing so; he isolated 119 previously unknown peptides.

Burzynski sent samples of his peptides to M D Anderson Cancer Center for testing. The results were unbelievable: some peptides selectively attacked cancer cells without harming normal cells. Cancer is called a neoplasm, or new formation. Burzynski decided to call his peptides, antineoplastons.  

Scientists then began grouping and labeling the various antineoplastons that Burzynski had discovered. One group was called antineoplaston A, one was antineoplaston L and another was antineoplaston O. Antineoplaston A was effective against a great variety of cancer cells; breast cancer, lymphoma, leukemia, bone, and brain cancers. Antineoplaston L had a more specific activity against leukemia while antineoplaston O was effective against osteosarcoma (bone cancer). Burzynski focused on antineoplaston A because of its activity against a wide variety of cancers. When animal studies showed that the substance had zero toxicity, his theory was completely formed and ready for publication.

He presented his theory in the spring of 1976 at the Annual Meeting of Federation of American Societies for Experimental Biology, the largest meeting in the US at that time.

A year after this presentation, he found that he had lost his funding. Few options were open to him. He could work for almost any clinic or research institute as a researcher or teacher, or he could open a research institute. He’d already begun a growing private practice in association with a prominent Houston doctor that started up as an offshoot from his cancer research.

He chose to go into private practice hoping to bring in funding for his research. He began treating patients with antineoplastons in 1976,  but his research laboratory opened in 1977.

In the years that followed, Dr Burzynski took a lot of shots from the medical community. They called him a “clever opportunist” who exploited people with cancer by offering them an expensive and ineffective, possibly dangerous cancer “cure” than came from urine.  Since 1980, Dr. Burzynski began using synthetic antineoplastons that replaced those isolated from urine.

In July of 1985, the FDA, along with members of Harris County Sheriff’s office, barged into Burzynski’s clinic seizing over 200,000 documents (research papers, patient records) and confiscating 11 file cabinets. They loaded everything into a U-Haul and drove away.

This was just the beginning of Dr Burzynski’s troubles. Over the next twelve years he would be driven to the point of bankruptcy battling the FDA, insurance companies, the Texas Board of Medical Examiners and Health Department, and the postal service for charges of mail fraud.

Burzynski’s lowest point was sitting in a courtroom facing up to 270 years in prison for saving lives that no other person on earth could help.

In our interview with the good Doctor and his wife, we were told that we really shouldn’t focus on this period in his life and we’ll gladly let you read about it through links provided at the end of this article.

However, to summarize the outcome of Dr Burzynski’s plight, we can say that, after initial studies of his antineoplastons had shown great promise, the NCI and the Mayo Clinic pronounced them worthless, the American Cancer Society called them dangerous, and Burzynski was labeled a quack and a charlatan.

The courts, after hearing the evidence, determined that antineoplastons are indeed “necessary to meet the patients' immediate needs for survival,” and that his treatment was effective for some deadly brain cancers.

The Texas Board of Medical Examiners continued to attack. The judged slapped them upside the head calling their decision:

"In excess of the agency's statutory authority, not reasonably supported by substantial evidence, capricious or arbitrary, and characterized by abuse of discretion."

All in all the facts stood for themselves. People came forward who testified that they would be dead today if not for Burzynski’s therapy. Others, outside the bastions of  our repressive, money driven, pharmaceutical industry controlled medical system, have tested antineoplastons and have declared them to be not only successful in reversing a variety of cancers, but that they are wonderful preventatives.

Dr. Burzynski too felt that they would make a pretty good preventative. He noticed that while patients underwent his therapy, that they just looked better. Their eyes were brighter, their hair color came back, wrinkles seemed to vanish and their immune systems were strengthened.

So, while preparing for his FDA monitored Phase II trials, he invented supplements and creams and lotions based on his technology.

Please note that antineoplastons are no longer collected from blood or urine, but since 1980 synthesized in a pharmaceutical plant. Burzynski also has licensed pharmaceutical companies throughout the country and the world to produce his supplements.

His supplement, Aminocare® A10 is a mixture of amino acids, amino acid derivative (his antineoplaston technology), and vitamin B2. His creams and lotions also contain these same amino acid derivatives along with some very healthy oils. They’ve been tested in France and the results were astounding. The researchers traced the genes affected by his therapy and reported back that his creams reduced wrinkles at the genetic level. You can read more about his supplements here: Aminocare® A10.

The sale of his supplements supports the research at the Burzynski Clinic in Houston.

Dr Burzynski told me, “If I were to die tomorrow, I would die a happy man.”

His therapy works. The results of his Phase II studies show conclusively that antineoplastons are effective against a wide range of malignancies (which now needs to be confirmed by the FDA). He now knows, as well, those cancers that antineoplastons cannot help. “Testicular cancer is one, “he told me, “and childhood leukemia.” But we both knew that conventional medicine has already taken care of those things.

Today, much of the research into genetic causes and cures for cancer are based upon his initial theories presented in 1976 presentation at the Annual Meeting  of Federation of American Societies for Experimental Biology.

 “Times are changing,” he smiled. “My therapy isn’t going away. I’ve saved hundreds of lives, antineoplastons will be here for years to come, medicine has to admit that we’ve accomplished something great here.”

Dr. Burzynski is in his sixties now. He looks younger than me. His hair is golden brown, not a hint of grey, and his smile is contagious. He drinks Polish mineral water, takes his own supplements, and saves lives.

 

References and further reading:

Antineoplastons - what they are, how they work

Ralph Moss on Burzynski

Burzynski Patient Group

FDA's War on Dr. Burzynski and His Patients: Physician and Patients Win!

Long-Term Survival and Complete Response of a Patient with Recurrent Diffuse Intrinsic Brain Stem Glioblastoma Multiforme  

Fighting Cancer—and the FDA

Trials of a cancer doc: experimental drugs and a 20-year fight with the FDA

The Burzynski Therapy for Cancer

Is There A Duty To Recommend Quack Cures?  [Interesting article. I love how they call antineoplastons a Quack Cure.]

Malignant Law Enforcement -- The FDA's war against an unorthodox cancer doctor.

The Police State of Medicine - The Nature of the Beast

The Other Drug War

Racketeering in Medicine: The Suppression of Alternatives
Racketeering in Medicine: The Suppression of Alternatives

Cancer Industry: The Classic Expose on the Cancer Establishment
Cancer Industry: The Classic Expose on the Cancer Establishment

Questioning Chemotherapy: A Critique of the Use of Toxic Drugs in the Treatment of Cancer
Questioning Chemotherapy: A Critique of the Use of Toxic Drugs in the Treatment of Cancer

Second Edition of the International Wellness Directory - unavailable (but slated to be updated and republished)

Speech by Gary Null, PhD, May 15, 1994 http://www.immunemedicine.com/paper1.asp

http://www.immunemedicine.com/objectives.asp

CANCER FACTS

AN OPEN SEASON ON 'QUACKS'

http://www.meaningoflife.i12.com/Cancer2.htm 

 

 Articles TOC

International Wellness Directory Home Page

Copyright © 2004, 2005
International Wellness Directory
Contact us

For non commercial use: You may copy, print, reprint, and/or transfer this entire article, if and only if it is unmodified and in its complete state with this copyright notice attached and all the links work properly. All others must contact us in writing: Contact Us